Literature DB >> 26907631

Disturbed B-lymphocyte selection in autoimmune lymphoproliferative syndrome.

Ales Janda1, Klaus Schwarz2, Mirjam van der Burg3, Werner Vach4, Hanna Ijspeert3, Myriam Ricarda Lorenz5, Magdeldin Elgizouli6, Kathrin Pieper6, Paul Fisch7, Joachim Hagel6, Raquel Lorenzetti6, Maximilian Seidl8, Joachim Roesler9, Fabian Hauck10, Elisabetta Traggiai11, Carsten Speckmann1, Anne Rensing-Ehl6, Stephan Ehl1, Hermann Eibel6, Marta Rizzi12.   

Abstract

Fas is a transmembrane receptor involved in the maintenance of tolerance and immune homeostasis. In murine models, it has been shown to be essential for deletion of autoreactive B cells in the germinal center. The role of Fas in human B-cell selection and in development of autoimmunity in patients carrying FAS mutations is unclear. We analyzed patients with either a somatic FAS mutation or a germline FAS mutation and somatic loss-of-heterozygosity, which allows comparing the fate of B cells with impaired vs normal Fas signaling within the same individual. Class-switched memory B cells showed: accumulation of FAS-mutated B cells; failure to enrich single V, D, J genes and single V-D, D-J gene combinations of the B-cell receptor variable region; increased frequency of variable regions with higher content of positively charged amino acids; and longer CDR3 and maintenance of polyreactive specificities. Importantly, Fas-deficient switched memory B cells showed increased rates of somatic hypermutation. Our data uncover a defect in B-cell selection in patients with FAS mutations, which has implications for the understanding of the pathogenesis of autoimmunity and lymphomagenesis of autoimmune lymphoproliferative syndrome.
© 2016 by The American Society of Hematology.

Entities:  

Keywords:  ALPS and B cells; ALPS and B-lymphocytes; ALPS and Rizzi; autoimmune lymphoproliferative syndrome and B cells

Mesh:

Substances:

Year:  2016        PMID: 26907631     DOI: 10.1182/blood-2015-04-642488

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Circulating B cells in type 1 diabetics exhibit fewer maturation-associated phenotypes.

Authors:  Patrick Hanley; Jennifer A Sutter; Noah G Goodman; Yangzhu Du; Debora R Sekiguchi; Wenzhao Meng; Michael R Rickels; Ali Naji; Eline T Luning Prak
Journal:  Clin Immunol       Date:  2017-09-23       Impact factor: 3.969

2.  Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome.

Authors:  Christian Klemann; Myrian Esquivel; Aude Magerus-Chatinet; Myriam R Lorenz; Ilka Fuchs; Nathalie Neveux; Martin Castelle; Jan Rohr; Claudia Bettoni da Cunha; Martin Ebinger; Robin Kobbe; Bernhard Kremens; Florian Kollert; Eleonora Gambineri; Kai Lehmberg; Markus G Seidel; Kathrin Siepermann; Thomas Voelker; Volker Schuster; Sigune Goldacker; Klaus Schwarz; Carsten Speckmann; Capucine Picard; Alain Fischer; Frederic Rieux-Laucat; Stephan Ehl; Anne Rensing-Ehl; Benedicte Neven
Journal:  Haematologica       Date:  2016-10-27       Impact factor: 9.941

3.  T and B cell clonal expansion in Ras-associated lymphoproliferative disease (RALD) as revealed by next-generation sequencing.

Authors:  S Levy-Mendelovich; A Lev; E Rechavi; O Barel; H Golan; B Bielorai; Y Neumann; A J Simon; R Somech
Journal:  Clin Exp Immunol       Date:  2017-06-05       Impact factor: 4.330

Review 4.  The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.

Authors:  Frédéric Rieux-Laucat; Aude Magérus-Chatinet; Bénédicte Neven
Journal:  J Clin Immunol       Date:  2018-06-17       Impact factor: 8.317

Review 5.  Autoimmune lymphoproliferative syndrome: more than a FAScinating disease.

Authors:  Karen Bride; David Teachey
Journal:  F1000Res       Date:  2017-11-01

Review 6.  Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance.

Authors:  Akiko Yamada; Rieko Arakaki; Masako Saito; Yasusei Kudo; Naozumi Ishimaru
Journal:  Front Immunol       Date:  2017-04-05       Impact factor: 7.561

7.  Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation.

Authors:  Fabienne Mazerolles; Marie-Claude Stolzenberg; Olivier Pelle; Capucine Picard; Benedicte Neven; Alain Fischer; Aude Magerus-Chatinet; Frederic Rieux-Laucat
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

Review 8.  Genetic Mosaicism as a Cause of Inborn Errors of Immunity.

Authors:  Jahnavi Aluri; Megan A Cooper
Journal:  J Clin Immunol       Date:  2021-04-16       Impact factor: 8.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.